PEA

Palmitoylethanolamide (PEA) and Benfotiamine is a synergistic combination to support nerve health, intestinal homeostasis, glucose metabolism, and inflammation. PEA is a strong inhibitor of mast cell activation, controls intestinal inflammation and permeability, and participates in homeostasis of the microbiome. Micronization is the process of taking a large molecule and reducing its particle size. Micronized PEA has improved solubility, making it more readily absorbable and usable by the body. Benfotiamine is a synthetic derivative of thiamine (vitamin B1) with high bioavailability and higher tissue penetration than thiamine. Benfotiamine supports nerve health and contributes to healthy glucose metabolism.